scispace - formally typeset
K

Kati Räsänen

Researcher at University of Helsinki

Publications -  13
Citations -  752

Kati Räsänen is an academic researcher from University of Helsinki. The author has contributed to research in topics: Nemosis & Tumor progression. The author has an hindex of 9, co-authored 12 publications receiving 670 citations.

Papers
More filters
Journal ArticleDOI

Activation of fibroblasts in cancer stroma.

TL;DR: This review focuses mainly on carcinomas and discusses the recent findings regarding the role of activated fibroblasts in driving tumor progression.
Journal ArticleDOI

Nemosis, a novel way of fibroblast activation, in inflammation and cancer.

TL;DR: The results suggest that this kind of fibroblast activation (nemosis) may be involved in pathological conditions such as inflammation and cancer.
Journal ArticleDOI

TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.

TL;DR: TGF-beta1 operates via distinct mechanisms in inducing EMT and metastasis, and supporting this it is shown that TGF- beta1 induces COX-2 and promotes the migration of benign cells, but does not further augment the Migration of malignant cells, indicating their resistance to TGF -beta1 in the context of motility.
Journal ArticleDOI

Emerging Roles of SPINK1 in Cancer

TL;DR: Assessing the role of SPINK1 in cancer has several potentially important clinical applications ranging from a biomarker to a potential new target for cancer therapy.
Journal ArticleDOI

Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma

TL;DR: Nemosis response, as observed by COX-2 and growth factor induction, and expression of CAF markers α-SMA, FSP1 and FAP, varies between fibroblast populations, emphasize the heterogeneity of fibroblasts and the evolving tumor-promoting properties of CAFs.